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In these complex times, when public opinion is a litmus test
of any profession’s or organization’s image, reputation, and
operational methods, it is increasingly clear that the College
is in need of guidelines that explicitly define its relationships
with commercial, nonprofit, and government organizations
and its relationships with individual members and support-
ers. Such an ethical protocol would serve as a useful road
map in support of the values the College holds paramount,
an important compass in navigating unfamiliar terrain that
may be encountered as the College boldly steps forward
with new partners, new programs, and new initiatives on
behalf of the cardiovascular specialty. As the leading voice in
cardiovascular medicine, both nationally and internation-
ally, the College’s role is essential to greater national
progress in quality health care. In my view, having an
unchallengeable institutional code of ethical conduct is
equally essential as the ACC moves toward that goal. The
reference list at the end of this article indicates some
material related to this discussion and is provided as
recommended reading (1–7).
Ethical issues relevant to individuals and professional
societies are coming under closer scrutiny. More frequently,
the news media report on unethical and illegal business
conduct, and not just in Fortune 500 corporate board
rooms. These headline stories touch off discussions about
ethical standards in all organizations that depend on corpo-
rate support and the philanthropy of professional/business
leaders. Many leading figures in our professional society
question whether the College should engage in any kind of
relationship with a business organization that acknowledges
involvement in unethical practices or has become the subject
of investigation by a federal agency. For example, should the
College accept funding for an educational program from a
company that’s been indicted for fraud? Should it take
disciplinary action against a member who provides mislead-
ing testimony in a medical liability case? Up until now, these
kinds of circumstances have not been considered by the
ACC, with the exception of expelling members who are
convicted felons.
RESPONSIBILITY TO ETHICAL, LAW-ABIDING
FELLOWS
The College’s conduct and business relationships raise
ethical questions about its obligation to its members.
Shouldn’t the College’s conduct reflect values based on the
Hippocratic Oath? Isn’t the College responsible for protect-
ing its membership from negative exposure of any kind—
even from the actions of a single Fellow engaged in
unethical or unlawful conduct? And doesn’t the College
have an obligation to maintain the position and practice of
cardiovascular medicine at the very highest ethical plane?
Presently, the organizational will to create a code of
ethical conduct is flourishing. Next spring, the ACC and
the American Heart Association (AHA) will hold a con-
ference chaired by Dr. Richard Popp, on behalf of the
ACC, and Dr. Sidney Smith, on behalf of the AHA. The
conference will explore a code that would describe official
business relationships where they affect cardiovascular prac-
tice and fiscal transactions carried out by staff and volunteer
leadership on behalf of either organization. Conference
leaders will focus on relationships with industry partners
that may be vulnerable to the appearance of conflict of
interest, issues of self-referral in patient care, and issues that
relate to the independence of investigators doing clinical
research with funding from industry sponsors.
In a speech delivered at ACC ’03, my immediate prede-
cessor, W. Bruce Fye, MD (3), questioned how clinical
trials and guidelines, supported with industry funds, influ-
ence the ethics of cardiovascular practice. He noted that
conflicts of interest can arise in the industry–academic
relationship but must be minimized to ensure the integrity
of clinical research—by no means an easy task. According to
a health policy report recently published in The New
England Journal of Medicine (7), policies at academic and
professional institutions vary substantially with regard to
procedural safeguards in research, with most policies lacking
procedural teeth despite the availability of a model for policy
and guidelines that was developed by the Office of Research
Integrity at the U.S. Department of Health and Human
Services.
THE CASE FOR PEER REVIEW
Any ethical code the College adopts should be reflected in
the conduct of its members as well. Yet, the ACC has
received a number of complaints from members purporting
a lack of integrity in their professional peers who testify as
expert witnesses in medical liability cases. Some professional
societies require members who serve as expert witnesses to
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submit their testimony for peer review. If a peer review finds
testimony to be lacking in factual basis, then the member is
sanctioned, given a warning, or even suspended from the
respective professional society. Making mediation even
more difficult, of course, is the fact that the “standard of
care” is not always clear-cut even among expert practitio-
ners.
In an article published in JACC in 2002, Michael S.
Lauer, MD, FACC (6), wrote of his experience with
non-peer-reviewed testimony in a medical liability lawsuit
filed against him. The plaintiff’s case revolved around the
testimony of one expert witness who had never performed
any kind of peer-reviewed research or systematic review of
the condition under investigation, myocardial sarcoid. None
of the evidence presented against Dr. Lauer was based on
randomized trials, high-quality observational studies, or
even published practice guidelines; yet, a lay jury was left to
ponder its validity. His experience led him to conclude that,
at minimum, expert testimony must pass a peer review to
increase its credibility before a jury.
The College’s Ethics and Discipline Committee is cur-
rently exploring the creation of a professional conduct
program modeled after one adopted by the American
Association of Neurological Surgeons (AANS). The North
American Spine Society (NASS) has adopted a similar
program. These organizational declarations of acceptable
conduct move their respective professional associations to
the forefront of medical societies in creating the highest
ethical performance standards with regard to patients, the
judicial system, and one another. The code adopted by
NASS last year outlines acceptable ethical relationships as
they pertain to health care providers, patients and their
families, and the legal profession. It also outlines the
organization’s responsibility to government, health care
payers, the medical community, and the global spinal care
community. Expert witness guidelines are included as well.
Clearly, it is a comprehensive code, useful as a model to the
ACC.
DEFINING COLLEGE ETHICS
Ethical boundaries between individual physicians and in-
dustry must be explicitly defined because, as Dr. Fye
reminded us in Chicago, a “blend of altruism and self-
interest motivates each individual, institution, and company
involved in every phase of health care, whether it’s inventing
drugs, conducting trials, developing guidelines, educating
doctors, or performing procedures.” Our altruism as physi-
cians must be at the foundation of our guiding principles
both as an organization and as individual ACC members.
Given the College’s reliance on corporate support, as well
as support from individuals, the College would be wise to
negotiate an ethical contract with itself before a critical
point of vulnerability arises. When should it bow out or
refuse a partnership? When does the ethical conduct of a
single member require action to protect the reputations of
the ACC Fellows with whom he/she stands? Without a set
of “golden rules,” are we absolutely certain where the
College stands, or with whom? An explicit code of ethics—
declared, written, and voted into policy—would further
enable the ACC to clearly demonstrate its intentions and
strengths for the benefit of all who might challenge our
integrity, our altruism, or our zeal in pursuing our mission.
It would create a new asset with which to identify the
College as it enters into new business relationships with a
range of new partners and supporters.
I have asked ACC staff and attorneys for their opinions
on the appropriate code of ethics for the College and would
welcome your opinion as a valued member as well. Please
send me your thoughts on this important initiative while it
is still being formed.
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